IBO:CC - UNIVERSAL IBOGAINE Engages Investor Relations Firm Blue Digital Media
(TheNewswire)
Calgary, AB – TheNewswire- June 13, 2022 – Universal Ibogaine Inc. (TSXV:IBO ) , ( OTC:IBOGF ) and ( FSE:JC4) (“ UI ” or the “ Company ”) a life sciences company with a mission totransform addiction treatment through the use of medicalized ibogaineand a global licensing model advises it has engaged investorcommunications firm Blue Digital Media & Web Solutions(“ BlueDigital ”) for assistancewith expanding awareness of UI’s business activities.
Blue Digital will provide expanded distribution of the UI story across multiple channels andaudiences. The expected result is increased awareness of UI’s plans for research into utilizing ibogaine as part of the deliveryof a continuum of care treating opioid abuse and otheraddictions.
Blue Digital will receive compensation of USD 27,000for a 3 month engagement effective June 13, 2022. In addition, BlueDigital will receive a total of 450,000 stock options to purchasecommon shares of the Company, with an exercise price of $0.10 pershare, a term of 3 years to expiry, and vesting one-third at the endof each month of the term of service.
Nick Karos, UI’s Chief Executive Officer, noted “Weare pleased to have access to Blue Digital’s distribution channels,as their reach across borders will expand awareness of our businessto new audiences. Addiction knows no boundaries and so the solutionwe pursue must also be global in nature.”
About UniversalIbogaine Inc.
UI is a life sciences company, with a mission totransform addiction treatment using medicalized ibogaine through aplanned Canadian clinical trial focused on opioid use disorder, andultimately to utilize that protocol globally through planned futurelicensing agreements. UI is concurrently developing a state of the art holisticaddiction treatment protocol at its Kelburn Recovery Centre that, whenpaired with the planned ibogaine detox protocol, is intended torevolutionize the way we treat addiction and drastically improve thelives of individuals and families affected byaddiction.
NEITHER THE TSXVENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM ISDEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTSRESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THISRELEASE.
CAUTIONARY STATEMENTREGARDING FORWARD-LOOKING STATEMENTS
?This news release may containforward-looking statements and information. Forward-lookinginformation is frequently characterized by words such ?as"plans", "expect", "project","intend", "will", "believe","anticipate", "estimate", "scheduled",??"potential", or other similar words, or statementsthat certain events or conditions "may", "should"or ??"could" occur. The forward-looking statements andinformation are based on certain key expectations ?and assumptionsmade by UI. Although UI believes that the expectations andassumptions on which the forward-?looking statements are based arereasonable, undue reliance should not be placed on theforward-?looking statements because UI can give no assurance thatthey will prove to be correct.
Since ?forward-looking statementsaddress future events and conditions, by their very nature theyinvolve ?inherent risks and uncertainties. Actual results coulddiffer materially from those currently anticipated ?due to a numberof factors and risks, which include, but are not limited to, risksthat required ?regulatory approvals are not obtained. The reader iscautioned that assumptions used in the ?preparation of suchinformation, although considered reasonable by UI at the time of?preparation, may prove to be incorrect and readers are cautionednot to place undue reliance on ?forward-looking information, whichspeaks only to conditions as of the date hereof. UI does not?undertake any obligation to release publicly any revisions toforward-looking information contained ?herein to reflect events orcircumstances that occur after the date hereof or to reflect theoccurrence ?of unanticipated events, except as may be required underapplicable securities laws. ?
For furtherinformation:
InvestorRelations: Dugan Selkirk,IR Manager
dugan.selkirk@universalibogaine.com
Related Links
Copyright (c) 2022 TheNewswire - All rights reserved.